Vineet Laboratories
32.03
+0.76(+2.43%)
Market Cap₹61.52 Cr
PE Ratio-5.98
IndustryHealthcare
Company Performance:
1D+2.43%
1M+0.69%
6M-9.26%
1Y-10.05%
5Y-17.85%
View Company Insightsright
More news about Vineet Laboratories
18Nov 25
Vineet Laboratories Promoters Dispose 9.4 Lakh Equity Shares Through Market Sales
Promoters of Vineet Laboratories Limited have sold 9,40,975 equity shares through open market transactions on the NSE. This sale has decreased the promoter holding from 17.75% to 12.95% of the company's total share capital of 92,19,008 shares. The company has informed both BSE and NSE about these transactions, complying with SEBI regulations on insider trading disclosure.
 no imag found
08Nov 25
Vineet Laboratories Announces Board Changes and Reports Q2 FY2026 Results
Vineet Laboratories Limited has made significant board changes, including appointing Ms. Jasmin Kunal Tailor as a new Independent Director and the resignation of Ms. Hari Priya Yerukalapudi. The company reported Q2 FY2026 financial results with revenue from operations increasing to Rs. 1741.95 lakhs, up from Rs. 744.18 lakhs in Q1. Despite revenue growth, the company posted a net loss of Rs. 46.51 lakhs for H1 FY2026. Total assets as of September 30, 2025, stood at Rs. 9064.49 lakhs.
 no imag found
04Sept 25
Vineet Laboratories Promoters Sell Shares Worth ₹53.2 Lakh
Four promoters of Vineet Laboratories Limited sold a total of 154,213 shares worth ₹53.2 lakh on September 1, 2025, on the National Stock Exchange. Gaddam Venkata Ramana made the largest sale of 80,000 shares. The transactions resulted in reduced promoter shareholding, with individual stake reductions ranging from 0.26% to 0.87%. The company complied with SEBI regulations by informing stock exchanges through Form C.
 no imag found
18Aug 25
Vineet Laboratories Promoters Reduce Stakes in Separate Transactions
Two promoters of Vineet Laboratories Limited have reduced their shareholdings. Mrs. Gaddam Venkata Rama sold 1,50,000 shares, decreasing her stake from 2.82% to 1.19%. Mr. Satyanarayana Raju Bhupathiraju sold 56,164 shares, reducing his stake from 3.50% to 3.02%. Both transactions were conducted on the open market and disclosed in compliance with SEBI regulations.
 no imag found
12Aug 25
Vineet Laboratories Seeks Shareholder Approval for Capital Increase and Director Appointment
Vineet Laboratories Limited's Board of Directors has approved proposals requiring shareholder approval through a postal ballot. The key proposals include increasing the authorized share capital, raising financial thresholds for loans and investments, and appointing Mr. Premananda Reddy Vennapusa as a Non-Executive Director. The cut-off date for voting is set for August 8, 2025, with the board meeting held on August 12, 2025. The company has informed both BSE and NSE about these developments in compliance with SEBI regulations.
 no imag found
09Aug 25
Vineet Laboratories Promoters Reduce Stakes, Sell Shares Worth Over ₹3 Crore
Two promoters of Vineet Laboratories Limited have sold shares, reducing their stakes in the company. Satyanarayana Raju Bhupathiraju sold 18,728 shares on BSE, reducing his holding to 406,452 shares. Gaddam Venkata Rama sold 9,725 shares on NSE, decreasing her stake to 2.82% of total shareholding. The company has complied with SEBI regulations by promptly informing both BSE and NSE about these transactions.
 no imag found
08Aug 25
Vineet Laboratories Promoters Offload Shares Worth Over ₹1.4 Crore
Three promoters of Vineet Laboratories Limited have sold a total of 1,86,165 shares valued at approximately ₹59.06 lakh. Mrs. Gaddam Venkata Rama sold 1,10,000 shares, reducing her stake from 4.12% to 2.93%. Mr. Alluri Prabhakar Raju sold 49,165 shares, decreasing his holding from 2.58% to 2.05%. Mrs. Alluri Maithili offloaded 27,000 shares, lowering her stake from 1.68% to 1.38%. All transactions were executed on the NSE through on-market sales, in compliance with SEBI regulations.
 no imag found
24Jul 25
Vineet Laboratories Promoter Reduces Stake Through Two Share Sale Transactions
Valluru Vara Prasad Rao, a promoter of Vineet Laboratories Limited, has reduced his shareholding through two separate transactions on the NSE. The first sale of 607 shares reduced his stake from 17.97% to 17.37%. The second sale of 14,000 shares further decreased his holding to 14.15%. In total, the promoter's stake has been reduced by approximately 3.82 percentage points. The company has duly informed the stock exchanges about these transactions in compliance with SEBI regulations.
 no imag found
22Jul 25
Vineet Laboratories Reports Reduced Net Loss in Q1 FY2026
Vineet Laboratories Limited (VLL) reported a net loss of ₹86.61 lakh for Q1 FY2026, improving from a ₹213.07 lakh loss in Q1 FY2025. However, revenue declined sharply to ₹744.18 lakh from ₹2,386.16 lakh year-over-year. Total expenses were ₹836.14 lakh. The company's EPS improved to -₹0.94 from -₹2.31. As of June 30, 2025, total assets stood at ₹8,854.38 lakh, with total equity at ₹1,382.00 lakh. The Board approved these results on July 22, 2025, and auditors NSVR & Associates LLP issued an unqualified review report.
 no imag found
Vineet Laboratories
32.03
+0.76
(+2.43%)
1 Year Returns:-10.05%
Industry Peers
Sun Pharmaceutical
1,724.40
(+0.64%)
Divis Laboratories
6,291.00
(-0.10%)
Torrent Pharmaceuticals
4,241.70
(+0.36%)
Cipla
1,341.10
(+0.92%)
Dr Reddys Laboratories
1,280.40
(-0.15%)
Lupin
2,219.40
(-0.42%)
Zydus Life Science
900.75
(-0.18%)
Mankind Pharma
2,024.30
(-0.75%)
Aurobindo Pharma
1,158.80
(-1.08%)
Alkem Laboratories
5,392.00
(+0.28%)